Elevance Health reaffirmed its full-year 2026 earnings guidance during investor meetings, projecting at least $20.10 per diluted share including approximately $6.90 of net unfavorable items, or adjusted shareholders’ earnings of at least $27.00 per diluted share excluding those items. The company also maintained its benefit expense ratio forecast for 2026 at 90.2%, plus or minus 50 basis points. Elevance Health operates in the managed healthcare and insurance industry.
